Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 57 min ago
Peer-reviewedCC BY-NC-ND 4.0NPJ Vaccines

Muscle macrophage regenerative response after squalene-adjuvanted influenza vaccination is associated with type II-skewed response and is reduced with age

5 more authors
9 affiliations
  1. 1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY USA
  2. 2Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY USA
  3. 3Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY USA
  4. 4Department of Pharmaceutics, Ghent University, Ghent, Belgium
  5. 5Department of Medicine, Ghent University, Ghent, Belgium
  6. 6Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD USA
  7. 7Center for Vaccine Development and Global Health (CVD), University of Maryland School of Medicine, Baltimore, MD USA
  8. 8Icahn Genomics Institute, Icahn School of Medicine at Mount Sinai, New York, NY USA
  9. 9Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY USA

Abstract

Squalene-based adjuvants like MF59 and AddaVax induce transient muscle injury, but their downstream mechanisms remain unclear. We show that intramuscular injection of a quadrivalent inactivated influenza vaccine (QIV) with AddaVax triggers a muscle regenerative-like immune response, increasing CX3CR1⁺Ly6C⁺ macrophages in muscle and draining lymph nodes within four days. This promotes a type II-skewed immune response, with elevated IgG1 titers and Th2 cytokines in the lungs after influenza challenge. In aged mice, the macrophage response and type II skewing are diminished. Adoptive transfer of young mice bone marrow-derived macrophages into aged mice at vaccination leads to macrophage antigen uptake, lymph node migration, and type II immune bias. However, this restoration does not improve protection against mismatched viral challenge, suggesting additional age-related immune impairments. These findings highlight the role of macrophage-driven muscle regeneration in adjuvant activity and underscore the need to better understand how muscle damage and repair influence intramuscular vaccine efficacy.

Related

  1. Post-exposure vaccination with an adjuvanted protein subunit vaccine, but not BCG, protects mice and guinea pigs against M. tuberculosis
    Joshua S. Woodworth, Claus Aagaard, Francisco J. Salguero +4
    NPJ VaccinesPeer-reviewedCC BY-NC-ND 4.0Full textInfectious diseasePMC
  2. Shared and vaccine-specific factors associated with COVID-19 and influenza vaccination intentions among adults in Poland: a COM-B-informed cross-sectional study.
    Mariusz Duplaga, Magdalena Sikorska, Kinga Kowalska-Duplaga
    Frontiers in public healthPeer-reviewedCC BYFull textEpidemiology & public healthEurope PMCCrossref
  3. Economic analysis of adjuvanted trivalent influenza vaccine for older adults in the Korean National Immunization Program
    Eunha Shim, Byung Wook Eun, Won Suk Choi
    Frontiers in Public HealthPeer-reviewedCC BY 4.0Full textEpidemiology & public healthCrossrefEurope PMC
  4. Determinants of influenza vaccination during the 2021/2022 influenza season in the United States: interactive roles of immunosuppression, cancer diagnosis, and healthcare access barriers
    Oluwatobi Emmanuel Adegbile, Kehinde Kazeem Kanmodi, Oluwamisimi Mary Abib +1
    BMC Public HealthPeer-reviewedCC BY-NC-ND 4.0Epidemiology & public healthCrossref
  5. Immune microenvironment in rotator cuff healing: from macrophage dynamics to immunomodulatory regenerative therapies
    Feng Li, Zhengdao Fu, Xinhai Zhang +2
    Frontiers in bioengineering and biotechnologyPeer-reviewedCC BYFull textSurgery & anaesthesiaEurope PMCPMC
BibTeX
@article{noureddine2026muscle,
  title = {{Muscle macrophage regenerative response after squalene-adjuvanted influenza vaccination is associated with type II-skewed response and is reduced with age}},
  author = {Moataz Noureddine and Lauren A. Chang and Farah El Ayache and Gabriel Laghlali and Eleanor Burgess and Leonie Gruneberg and Prajakta Warang and Kaijun Jiang and Johanna Vandekerckhove and Vivian Yan and Haye Nijhuis and Lynda Coughlan and Bruno G. De Geest and Juan Garcia-Bernalt Diego and Seok-chan Park and Jorge Levican and Michael Schotsaert},
  journal = {NPJ Vaccines},
  year = {2026},
  month = jul,
  doi = {10.1038/s41541-026-01436-6},
  url = {https://doi.org/10.1038/s41541-026-01436-6},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - Muscle macrophage regenerative response after squalene-adjuvanted influenza vaccination is associated with type II-skewed response and is reduced with age
AU  - Moataz Noureddine
AU  - Lauren A. Chang
AU  - Farah El Ayache
AU  - Gabriel Laghlali
AU  - Eleanor Burgess
AU  - Leonie Gruneberg
AU  - Prajakta Warang
AU  - Kaijun Jiang
AU  - Johanna Vandekerckhove
AU  - Vivian Yan
AU  - Haye Nijhuis
AU  - Lynda Coughlan
AU  - Bruno G. De Geest
AU  - Juan Garcia-Bernalt Diego
AU  - Seok-chan Park
AU  - Jorge Levican
AU  - Michael Schotsaert
PY  - 2026
DA  - 2026/07/04
JO  - NPJ Vaccines
DO  - 10.1038/s41541-026-01436-6
UR  - https://doi.org/10.1038/s41541-026-01436-6
AB  - Squalene-based adjuvants like MF59 and AddaVax induce transient muscle injury, but their downstream mechanisms remain unclear. We show that intramuscular injection of a quadrivalent inactivated influenza vaccine (QIV) with AddaVax triggers a muscle regenerative-like immune response, increasing CX3CR1⁺Ly6C⁺ macrophages in muscle and draining lymph nodes within four days. This promotes a type II-skewed immune response, with elevated IgG1 titers and Th2 cytokines in the lungs after influenza challenge. In aged mice, the macrophage response and type II skewing are diminished. Adoptive transfer of young mice bone marrow-derived macrophages into aged mice at vaccination leads to macrophage antigen uptake, lymph node migration, and type II immune bias. However, this restoration does not improve protection against mismatched viral challenge, suggesting additional age-related immune impairments. These findings highlight the role of macrophage-driven muscle regeneration in adjuvant activity and underscore the need to better understand how muscle damage and repair influence intramuscular vaccine efficacy.
SN  - 2059-0105
ER  -